Xiaochen Zhang1, Ashley F Haggerty2, Justin C Brown3, Robert Giuntoli2, Lilie Lin4, Fiona Simpkins2, Lorraine T Dean3, Emily Ko2, Mark A Morgan2, Kathryn H Schmitz5. 1. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Pennsylvania Perelman School of Medicine, United States; Center for Clinical Epidemiology & Biostatistics, University of Pennsylvania Perelman School of Medicine, United States. 2. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Pennsylvania Perelman School of Medicine, United States. 3. Center for Clinical Epidemiology & Biostatistics, University of Pennsylvania Perelman School of Medicine, United States. 4. Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, United States. 5. Center for Clinical Epidemiology & Biostatistics, University of Pennsylvania Perelman School of Medicine, United States. Electronic address: schmitz@mail.med.upenn.edu.
Abstract
OBJECTIVE: To determine the proportion of endometrial cancer patients who can be safely prescribed community/home based unsupervised exercise. A better understanding of the physical dysfunction secondary to comorbidities among endometrial cancer patients would assist clinicians in delineating which patients to send to medically-based supervised rehabilitation versus a community/home based unsupervised exercise program. METHODS: A literature review identified health issues which could impede patients from successfully completing an unsupervised exercise program after a cancer diagnosis. The charts of 479 endometrial cancer patients treated between 2006 and 2010 were reviewed to determine the health status at the time of diagnosis and the type and percentage of health-issues that could preclude an unsupervised exercise program in this population. Univariable modeling and multivariable modeling were used to evaluate the association of demographic, cancer-related characteristics and clinical variables with ability to participate in unsupervised exercise. RESULTS: We determined that 14.2% of endometrial cancer patients were able to exercise without supervision based on their health status at the time of diagnosis. After excluding common comorbidities (hypertension, diabetes and morbid obesity) from the identified health-issues, the proportion increased to 20.5%. Older at diagnosis (P=0.007) and higher BMI (P<0.001) are more likely to exclude patients from community/home based unsupervised exercise program. CONCLUSIONS: Only 14.2% to 20.5% of endometrial cancer patients were deemed able to exercise without supervision based on their health status at diagnosis. Our data suggest that approximately 80% of endometrial cancer patients would benefit from a referral to a medically-based supervised exercise program.
OBJECTIVE: To determine the proportion of endometrial cancerpatients who can be safely prescribed community/home based unsupervised exercise. A better understanding of the physical dysfunction secondary to comorbidities among endometrial cancerpatients would assist clinicians in delineating which patients to send to medically-based supervised rehabilitation versus a community/home based unsupervised exercise program. METHODS: A literature review identified health issues which could impede patients from successfully completing an unsupervised exercise program after a cancer diagnosis. The charts of 479 endometrial cancerpatients treated between 2006 and 2010 were reviewed to determine the health status at the time of diagnosis and the type and percentage of health-issues that could preclude an unsupervised exercise program in this population. Univariable modeling and multivariable modeling were used to evaluate the association of demographic, cancer-related characteristics and clinical variables with ability to participate in unsupervised exercise. RESULTS: We determined that 14.2% of endometrial cancerpatients were able to exercise without supervision based on their health status at the time of diagnosis. After excluding common comorbidities (hypertension, diabetes and morbid obesity) from the identified health-issues, the proportion increased to 20.5%. Older at diagnosis (P=0.007) and higher BMI (P<0.001) are more likely to exclude patients from community/home based unsupervised exercise program. CONCLUSIONS: Only 14.2% to 20.5% of endometrial cancerpatients were deemed able to exercise without supervision based on their health status at diagnosis. Our data suggest that approximately 80% of endometrial cancerpatients would benefit from a referral to a medically-based supervised exercise program.
Authors: Kerry S Courneya; Kristina H Karvinen; Kristin L Campbell; Robert G Pearcey; George Dundas; Valerie Capstick; Katia S Tonkin Journal: Gynecol Oncol Date: 2005-05 Impact factor: 5.482
Authors: Miriam E Nelson; W Jack Rejeski; Steven N Blair; Pamela W Duncan; James O Judge; Abby C King; Carol A Macera; Carmen Castaneda-Sceppa Journal: Circulation Date: 2007-08-01 Impact factor: 29.690
Authors: Cheryl L Rock; Colleen Doyle; Wendy Demark-Wahnefried; Jeffrey Meyerhardt; Kerry S Courneya; Anna L Schwartz; Elisa V Bandera; Kathryn K Hamilton; Barbara Grant; Marji McCullough; Tim Byers; Ted Gansler Journal: CA Cancer J Clin Date: 2012-04-26 Impact factor: 508.702
Authors: Alice B Kornblith; Mark Powell; Meredith M Regan; Samantha Bennett; Carolyn Krasner; Beverly Moy; Jerry Younger; Annekathyrn Goodman; Ross Berkowitz; Eric Winer Journal: Psychooncology Date: 2007-10 Impact factor: 3.894
Authors: Kristy K Ward; Nina R Shah; Cheryl C Saenz; Michael T McHale; Edwin A Alvarez; Steven C Plaxe Journal: Gynecol Oncol Date: 2012-04-13 Impact factor: 5.482
Authors: Vivian E von Gruenigen; Kerry S Courneya; Heidi E Gibbons; Mary Beth Kavanagh; Steven E Waggoner; Edith Lerner Journal: Gynecol Oncol Date: 2008-02-19 Impact factor: 5.482
Authors: Alexander R Lucas; Brian C Focht; David E Cohn; Janet Buckworth; Maryanna D Klatt Journal: Integr Cancer Ther Date: 2016-09-14 Impact factor: 3.279
Authors: Wendy Demark-Wahnefried; Kathryn H Schmitz; Catherine M Alfano; Jennifer R Bail; Pamela J Goodwin; Cynthia A Thomson; Don W Bradley; Kerry S Courneya; Christie A Befort; Crystal S Denlinger; Jennifer A Ligibel; William H Dietz; Melinda R Stolley; Melinda L Irwin; Marcas M Bamman; Caroline M Apovian; Bernardine M Pinto; Kathleen Y Wolin; Rachel M Ballard; Andrew J Dannenberg; Elizabeth G Eakin; Matt M Longjohn; Susan D Raffa; Lucile L Adams-Campbell; Joanne S Buzaglo; Sharyl J Nass; Greta M Massetti; Erin P Balogh; Elizabeth S Kraft; Anand K Parekh; Darshak M Sanghavi; G Stephen Morris; Karen Basen-Engquist Journal: CA Cancer J Clin Date: 2017-11-22 Impact factor: 508.702